1. Home
  2. ABUS vs HSII Comparison

ABUS vs HSII Comparison

Compare ABUS & HSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • HSII
  • Stock Information
  • Founded
  • ABUS N/A
  • HSII 1953
  • Country
  • ABUS United States
  • HSII United States
  • Employees
  • ABUS N/A
  • HSII N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • HSII Diversified Commercial Services
  • Sector
  • ABUS Health Care
  • HSII Consumer Discretionary
  • Exchange
  • ABUS Nasdaq
  • HSII Nasdaq
  • Market Cap
  • ABUS 772.1M
  • HSII 688.2M
  • IPO Year
  • ABUS N/A
  • HSII 1999
  • Fundamental
  • Price
  • ABUS $4.55
  • HSII $35.91
  • Analyst Decision
  • ABUS Strong Buy
  • HSII Buy
  • Analyst Count
  • ABUS 3
  • HSII 2
  • Target Price
  • ABUS $4.67
  • HSII $36.50
  • AVG Volume (30 Days)
  • ABUS 1.1M
  • HSII 107.6K
  • Earning Date
  • ABUS 11-05-2024
  • HSII 10-23-2024
  • Dividend Yield
  • ABUS N/A
  • HSII 1.67%
  • EPS Growth
  • ABUS N/A
  • HSII N/A
  • EPS
  • ABUS N/A
  • HSII 1.84
  • Revenue
  • ABUS $10,061,000.00
  • HSII $1,060,145,000.00
  • Revenue This Year
  • ABUS N/A
  • HSII $5.95
  • Revenue Next Year
  • ABUS N/A
  • HSII $2.94
  • P/E Ratio
  • ABUS N/A
  • HSII $19.48
  • Revenue Growth
  • ABUS N/A
  • HSII 5.86
  • 52 Week Low
  • ABUS $1.69
  • HSII $22.52
  • 52 Week High
  • ABUS $4.56
  • HSII $41.94
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 80.58
  • HSII 42.85
  • Support Level
  • ABUS $3.79
  • HSII $37.03
  • Resistance Level
  • ABUS $3.92
  • HSII $38.85
  • Average True Range (ATR)
  • ABUS 0.14
  • HSII 0.91
  • MACD
  • ABUS 0.07
  • HSII -0.25
  • Stochastic Oscillator
  • ABUS 98.86
  • HSII 10.09

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

About HSII Heidrick & Struggles International Inc.

Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments includes the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.

Share on Social Networks: